3-Methoxy-4-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 98%, 100mg

Methyl 2-(3-bromophenyl)-2,2-difluoroacetate, 97%, 250mg

(E)-4-Styrylpyridine, 98%, 100mg

ASC-81 (APY81), 98.0%, 100mg

Pipettes graduées type 3, classe AS Petit emballage, 25 ml, Division, 0,1 ml, Extrémité avec bouchon en coton, oui, 3 pièces

2-(2-(2-Aminoacetamido)acetamido)acetic acid, 95.0%, 5g

3-Bromo-4-methylbenzamide, 95.0%, 5g

2-(2,2,2-trifluoroethoxy)benzaldehyde, 500mg

7-Octenoic acid, 95.0%, 5g

6-Chloro-3-iodopyridin-2-ylamine, 95.0%, 250mg

2-Amino-3,5-dibromopyrazine>98.0%(GC)1g

6-imino-3-methyl-1,4-diphenyl-1H,4H,5H,6H-pyrano[2,3-c]pyrazole-5-carbonitrile, 97%, 100mg

3-(2-(((4-(((Hexyloxy)carbonyl)carbamoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoic acid  (Dabigatran Impurity), 97%, 50mg